Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and ...

The CDC did not report any C. auris infections in South Carolina in 2025, although neighboring states contained cases. In ...

Clostridioides difficile is an uncommon but quite serious cause of diarrhea, and it is often associated with antibiotics.

A newly developed antibiotic, EVG7, shows strong potential against the dangerous gut bacterium C. difficile, working effectively at very low doses while reducing the risk of relapse. Credit: ...

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...

Exploring two complex cases of recurrent C. difficile infections unresponsive to antibiotics and FMT, and how naturopathic interventions supported long-term remission and restored quality of life. The ...

ABSTRACT: Background: Diagnosis of Clostridium difficile infection (CDI) is a major challenge in controlling the spread of virulent strains of C. difficile. However, testing for C. difficile is not ...

As its name suggests, toxic megacolon is a serious complication that can occur in people who have an inflammatory bowel disease (IBD) like ulcerative colitis (UC) or Crohn’s disease. Toxic megacolon ...

C. difficile infection recurrence rates were numerically lower with vancomycin than with placebo, though the difference was not significant. However, the results could be clinically meaningful, an ...

Clinical cure and no disease recurrence within 60 days for 66.7 percent in FMT group, 61.2 percent in vancomycin group. (HealthDay News) — Fecal microbiota transplantation (FMT) could be considered as ...